NCT04757922Enrolling by invitation
Stop Ovarian Cancer Young; Effect of the Opportunistic Salpingectomy on Age of Menopause
Source: ClinicalTrials.gov · Last updated 26 Jan 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study is to evaluate the long-term safety of on the onset of menopause.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 1200 (estimated)
- First submitted
- 5 Feb 2021
- Start date
- 1 Mar 2021
- Primary completion date
- 1 Jan 2035
- Lead sponsor
- Radboud University Medical Center
- Diseases
- Ovarian cancer
- NCT number
- NCT04757922
What you commit to
- Study type: Observational
- Planned participants: 1200
- From 1 Mar 2021 to the primary completion date, 1 Jan 2035
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous salpingectomy of oophorectomy
- Previous hysterectomy
- Underwent chemotherapy or radiation
Other illness
- Women with abnormal karyotype (such as Turner Syndrome and Fragile X syndrome)
Age
- Under the age of 35 or above 45
Other
- Postmenopausal status at enrolment
- Unable to understand the written or spoken Dutch language
Who the study is looking for
- Intervention group
- Undergoing an Opportunistic Salpingectomy as sterilization method
- Premenopausal status at enrolment
- Age between 30 and 45 years
- Will have residual ovarian tissue after surgery
- Able to understand the written or spoken Dutch language
- Gives consent for participating in surveys
- Control group
- Premenopausal status at enrolment
- Either sterilization by tubal ligation or no sterilization at all
- Age between 35 and 45 years
- Able to understand the written or spoken Dutch language
- Gives consent for participating in surveys
Age in the registry: 30 years to 45 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Catharina Ziekenhuis Coordinator of this site? Confirm its status | Eindhoven | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.